Experimental Biology And Medicine | Finanzwire

Basculer en Français

10097	Companies
206690	Keywords
136846	Articles
109549	Press releases

Headlines Articles Press releases Experimental Biology And Medicine

Home
Companies
Experimental Biology And Medicine

BRIEF

published on 06/18/2024 at 15:05, 1 year 9 months ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye

Diabetic Dry Eye Naltrexone Tear Production OGF-OGFr Pathway Ocular Complications
PRESS RELEASE

published on 06/18/2024 at 15:00, 1 year 9 months ago

New Study Examines How Topical Naltrexone Restores Tear Production in Diabetic Dry Eye
Study led by Dr. Pat McLaughlin reveals topical naltrexone's effectiveness in reversing dry eye in diabetic rats. Findings point to OGF-OGFr pathway blockade as a promising treatment approach

Diabetes Experimental Biology And Medicine Naltrexone OGF-OGFr Pathway Dry Eye
BRIEF

published on 04/03/2024 at 15:05, 1 year 11 months ago

HTERT Vaccine Shows Promise in Therapy-Resistant Cancer Patients, Study Finds

Cancer Immunotherapy HTERT Vaccination Therapy-resistant Cancer Immune Response King's College London
PRESS RELEASE

published on 04/03/2024 at 15:00, 1 year 11 months ago

Study Shows hTERT Vaccination Induces Immunological Responses and Prevents Progression in a Subset of Therapy-Resistant Poor Prognosis Cancer Patients
A Phase 1 clinical trial led by James Spicer at King's College London showcases promising developments in immune therapy for solid tumours via hTERT vaccination. Published in Experimental Biology and Medicine

Solid Tumors Clinical Trial HTERT Vaccination Immune Therapy Experimental Biology And Medicine

Accesswire

Published on 03/26/2026 at 11:07, 23 minutes ago

U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 30 minutes ago

Pivotree Announces Fourth Quarter 2025 Results
Published on 03/26/2026 at 11:00, 30 minutes ago

Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 25 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 35 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 11:03, 26 minutes ago

EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 29 minutes ago

Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 29 minutes ago

Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 29 minutes ago

ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 29 minutes ago

Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months

Les Echos

Published on 03/26/2026 at 08:57, 2 hours 32 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 4 hours ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 16 hours 36 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 16 hours 58 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 45 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE